Cellen

25/01/2021

We were delighted to present in the COVID-19 category at Royal College of Physician's (RCP) Medicine 2021. Cellen is proud to be actively engaged in a variety of research projects, and this January 2021 we were able to showcase some of our latest work at this International conference.

Read more in our latest blog by our Chief Medical Officer, Dr Benjamin Viaris de Lesegno:

We were delighted to be selected as one of 50 abstracts to present in the COVID-19 category at Royal College of Physician's Medicine 2021.

08/09/2020

For , we have published our recent webinar on the future of chronic pain management for patients following COVID-19. We were joined by over 200+ healthcare professionals, patients and industry leaders in chronic pain.

Watch the webinar here and read more about the event with experts from Health Innovation Network & Care UK : https://www.cellenhealth.com/post/webinar-covid-19-chronic-pain-management

In August 2020, Cellen hosted a 1 hour webinar with The Digital Healthcare Show on the future of Chronic Conditions and Pain Management. The webinar was hosted by Cellen's Dr Mala Mawkin, and was attended by over 200+ leaders in the chronic pain sector.

17/08/2020

Cellen has been featured on the The Health-Tech Podcast this week. Join Cellen's Dr Mala Mawkin in conversation with Dr. James Somauroo. They speak about Cellen's team, mission and how we can improve the health and wellbeing of people living with chronic conditions using technology-enabled solutions.

Listen to the episode here:

Apple: https://podcasts.apple.com/gb/podcast/122-digital-health-podcasting-and-the-future/id1438968893?i=1000488276857

Spotify: https://open.spotify.com/episode/7lyJOHFRykdF27OHEECQJI

Listen to this episode from The Health-Tech Podcast on Spotify. For this week's Sunday Session, James is joined by Dr Mala Mawkin, award winning doctor, speaker and writer. Mala is featured on Forbes 30 Under 30, Vogue 10 Rising Female Stars and UK Women of the Future Awards Finalist. She is the Hos...

10/08/2020

Sign up to our latest Webinar on the 12th of August on Chronic Conditions and Pain Management hosted by Cellen's Dr Mala Mawkin.
⁣
The expert panel will explore how the pandemic has hugely altered the treatment of patients with chronic conditions, and specifically delayed the pain treatments of an estimated 150,000 people. We will discuss how best we can look after the increased number of ‘left behind’ patients requiring pain management, and how we can build clinician understanding and education on the available solutions.⁣
⁣
Our panel of sector experts include: ⁣
⁣
Mohammed Yousaf Ahmad- Chief Pharmacist of Care UK, UK Clinical Pharmacy Association Specialist Pain Committee Educational Lead, General Pharmaceutical Council Board Member and Teacher Practitioner, Queens University Belfast⁣
⁣
Natasha Curran- Consultant in Anaesthesia & Pain Medicine, Medical Director at Health Innovation Network, Joint Director of Clinical Strategy Kings Health Partners⁣
⁣
Dr Haggai Sharon - Honorary Consultant at the Pain Management & Neuromodulation Centre at Guy's & St Thomas' NHS Foundation Trust⁣
⁣
Sign up here: https://www.bigmarker.com/closerstill-media/The-COVID-effect-Chronic-Conditions-and-Pain-Management?show_live_page=true⁣
⁣

04/08/2020

Medical Cannabis in the UK is still very difficult to access for patients living with chronic conditions. After a successful beta test, Project Twenty 21 is officially live and will aim to enrol 20,000 patients over the next 2 years to understand safety and efficacy of the treatment. As a UK based, independent company, we are thrilled at Cellen to be a partner of this project which will be the largest European observational registry of patients taking prescribed Medical Cannabis.

Project Twenty21 is now live and signposting patients towards medical cannabis prescribing clinics across the country! To help you navigate the project, we h...

29/07/2020

Join us tonight for a webinar with MedCan. Our Chief Medical Officer will be answering questions on the Future of Medical Cannabis in the UK!

14/07/2020

In our latest blog, Dr Panagiotis Pardalidis talks about the need for improving Medical Cannabis education for NHS Doctors. Join us at our webinar tomorrow with The UK MCCS to learn more on this topic (sign up link in blog post). https://www.cellenhealth.com/post/improving-medical-cannabis-education-for-nhs-doctors

13/07/2020

Join us at our free webinar this Wednesday with The Medical Cannabis Clinicians Society (MCCS). Sign up here: https://zoom.us/webinar/register/WN_pAGwjdj0Rgqg1jPE-ymUuA

Dr Benjamin Viaris de Legeno from Cellen will be speaking with Professor Mike Barnes and Hannah Deacon from the MCCS. We are looking forward to the discussion!

30/06/2020

Listen to the latest Big Picture Medicine podcast to hear how Cellen is leading the UK Medical Cannabis market, and about innovating in the healthcare industry

Apple: https://podcasts.apple.com/gb/podcast/016-medical-cannabis-101-dr-benjamin-viaris-lesegno/id1500446262?i=1000480033184

Spotify: https://open.spotify.com/episode/46TNRe2xshHdRG6PkKcEL4

19/06/2020

We are thrilled to have been featured on Health Europa for our work in improving research, cost & supply and patient access to Medical Cannabis in the UK.

"With Cellen establishing a research led and patient-centred approach, the UK market is responding with optimism on the future of this medication."

Unfortunately, it remains challenging for UK patients to access medical cannabis – but Cellen Therapeutics is working to break down those barriers.

17/06/2020

New Podcast 🎧: Our Co-founders Dr Benjamin Viaris de Lesegno & Eric Bystrom were recently interviewed on the Digital Health STB Podcast! As a research driven company focussed on improving the health of people living with chronic conditions, we were delighted to be invited onto the show by Duncan Goldie.⁣
⁣
You can listen to the full episode here: https://open.spotify.com/episode/1brhwhbgq4MYTOYMQYhEuE?si=pB_NFiN7SHqHkupR35L8Dw⁣
⁣
"These guys are the founders; CEO and CMO and as you'll quickly find out, theyre 100% committed to their patients with chronic ailments. Cellen is a manufacturing, distribution and supply chain business for medical cannabis pharmaceutical products related to chronic ailments and diseases. The guys have implemented both a technically sound product and also a mentality to their business that is very rare to see within such early stage healthcare technology businesses, particularly those that operate outside the NHS. I hope you all find it as refreshing and inspiring as me!"⁣
⁣
We would love to hear your thoughts on the episode! ⁣
⁣

11/06/2020

Confused about the rumours on CBD & COVID-19? Cellen's Chief Medical Officer, Dr Benjamin Viaris de Lesegno, has recently written a blog post. ⁣
⁣
"As a researcher and NHS consultant with an interest in Medical Cannabis, I have been following the press and rumours regarding CBD & COVID-19. I wanted to dispel the myths behind this and discuss the current scientific status." ⁣
⁣
Have a read of his the full blog at : https://www.cellenhealth.com/post/cbd-does-not-cure-covid-19

Our Chief Medical Officer, Dr Benjamin Viaris de Lesegno, explores the science behind the widely discussed claims.